Sanofi sets up a major R&D hub in booming Shanghai – FierceBiotech

French pharma giant Sanofi ($SNY) has opened a major new R&D center in Shanghai with plans to employ 1,400 staffers while bringing together the drug development work being done in a dozen different Pacific Rim countries. Sanofi’s fifth big R&D hub will integrate work being done on biopharmaceuticals, rare diseases, vaccines and animal health. And highlighting the center’s new role as a central dealmaking spot, Sanofi also put out the word on two new research partnerships that will be coordinated in Shanghai.

Sanofi says it will now work with the GPCR Institute on new diabetes “breakthroughs” while collaborating with ZAI Lab on respiratory ailments.

Read more – FierceBiotech